安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Anavasi Diagnostics
The AscencioDx Molecular Detector, a rapid portable diagnostic tool, has become integral in medical settings, delivering positive results in as few as 20 minutes This device is especially beneficial in environments such as physicians' offices, urgent care clinics, pharmacies, and other point-of-care facilities
- About Us - Anavasi Diagnostics
Anavasi Diagnostics is the manufacturer of a Molecular SARS-CoV-2 Diagnostic Test for COVID-19 called the AscencioDx® COVID 19 Molecular Diagnostic System
- Covid-19 Test - Anavasi Diagnostics
Anavasi In The News Industry News Team Talk for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U S C § 360bbb-3(b)(1), unless the declaration is
- FAQs - Anavasi Diagnostics
The AscencioDx COVID-19 test system has two elements: The AscencioDx COVID-19 Test and The AscencioDx Molecular Detector The kit is packaged and sold separately from the detector, but together they make up an in vitro diagnostic testing system for the presence of COVID-19
- Our Team - Anavasi Diagnostics
As a seasoned leader and strategist in the molecular and clinical diagnostics field, Scott has over 20 years of experience in the in vitro diagnostics (IVD), healthcare manufacturing and distribution industries
- Molecular Detector - Anavasi Diagnostics
The AscencioDx Molecular Detector is a rapid, highly accurate, easy-to-use medical device for conducting NAAT analysis of samples collected from patients in point-of-care (POC) settings with in vitro diagnostic supplies It uses The AscencioDx COVID-19 Test
- Contact Information - Anavasi Diagnostics
Anavasi Diagnostics 15305 NE 95th Street Redmond, WA 98052 PH: 888-ANAVASI (262-8274)
- Documentation - Anavasi Diagnostics
The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U S C § 360bbb-3(b)(1), unless the
|
|
|